{"chebi_id":"85993","chebi_name":"palbociclib","chebi_synonyms":["IBRANCE","6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one","PD 332991","PD0332991","PD-0332991","UNII-G9ZF61LE7G","PD 0332991","6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one"],"diffprof_id_observed":["MTBLS2871_0001_00000009"],"diffprof_id_var_observed":["MTBLS2871_0001_00000009"],"inchikey":"AHJRHEGDXFFMBM-UHFFFAOYSA-N","inn_name":"palbociclib","iupac_name":"6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-<em>d</em>]pyrimidin-7(8<em>H</em>)-one","num_study_observed":1,"reactome_ids":["R-HSA-1640170","R-HSA-453279","R-HSA-69231","R-HSA-69236","R-HSA-69278","R-HSA-9754119"],"reactome_names":["Cell Cycle","Mitotic G1 phase and G1/S transition","Cyclin D associated events in G1","G1 Phase","Cell Cycle, Mitotic","Drug-mediated inhibition of CDK4/CDK6 activity"],"study_id_observed":["MTBLS2871"],"study_id_var_observed":["MTBLS2871"],"synonym_name":"PD0332991"}